The activity of recent anti-allergic drugs in the treatment of seasonal allergic rhinitis

Acta Oto-Rhino-Laryngologica Belgica

Volumn 50, Issue 1, 1996, Pages 25-32

  Wang, D ^a   Clement, P ^a   Smitz, J ^a   De Waele, M ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

anti allergic drugs; eosinophils; mediators; nasal allergen challenge; seasonal allergic rhinitis

Indexed keywords

AZELASTINE; BUDESONIDE; CETIRIZINE; CIMETIDINE;

ADULT; ALLERGIC RHINITIS; ALLERGY; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EOSINOPHIL; FEMALE; HUMAN; MALE; NOSE; ORAL DRUG ADMINISTRATION; SEASONAL VARIATION; TOPICAL DRUG ADMINISTRATION;

ADULT; AIRWAY RESISTANCE; ANTI-ALLERGIC AGENTS; BRONCHODILATOR AGENTS; BUDESONIDE; CIMETIDINE; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; MUCUS; NASAL PROVOCATION TESTS; PHTHALAZINES; PREGNENEDIONES; RHINITIS, ALLERGIC, SEASONAL;

EID: 0029922055     PISSN: 00016497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. LANGER H. M. Allergic rhinitis : a medical insight. J. Otolaryngol., 18 : 158-164, 1989.
2. BERMAN B. A. Allergic rhinitis : mechanisms and management. J. Allergy Clin. Immunol., 81 : 980-991, 1988.
3. SMAI I. P. Allergic rhinitis : some recent changes in treatment. Am. J. Rhinol. 1 : 127-133, 1987.
4. COREY J. P. Advances in the pharmacotherapy of allergic rhinitis : second-generation H1-receptor antagonists. Otolarygol. Head Neck Surg., 109 : 584-592, 1993.
5. WANG D. Y., CLEMENT P., SMITZ J., DERDE M.-P. Concentrations of chemical mediators in the nasal secretions after nasal allergen challenge in atopic patients. Eur. Arch. Otorhinolaryngol., 252 (Suppl.) : S40-S43, 1995.
6. WANG D. Y., CLEMENT P., SMITZ J., DE WAELE M., DERDE M.-P. Correlations between complaints, inflammatory cells and mediators after nasal allergen challenge and during natural allergen exposure. Int. Arch. Allergy Immunol., 106 : 278-285, 1995.
7. CLEMENT P. A. R., VAN DISHOECK A., VAN DE WAI J., STOOP P., HOEK T., VAN STRICK R. Nasal provocation and passive anterior rhinomanometry (PAR). Clin Allergy, 11 : 293-301, 1981.
8. BEIWENGA J., STOOP A. E., BAKER H. E., et al. Nasal secretions from patients with polyps and healthy individuals, collected with a new aspiration system : evaluation of total protein and immunoglobulin concentrations. Ann. Clin. Biochem., 28 : 260-266, 1991.
9. GERTH VAN WIJK R., DIEGES P. H. Comparison of nasal responsiveness to histamine, methacholine and phentolamine in allergic rhinitis patients and controls. Clin. Allergy, 17 : 563-570, 1987.
10. WANG D. Y., CLEMENT P., SMITZ J., DERDE M.-P. Concentrations of chemical mediators in nasal secretions of patients with hay fever during natural allergen exposure. Acta Otolarynol. (Stockh.), 114 : 552-555, 1994.
11. GASTPAR H., AURICH R., PETZOLD U., VIRNKAES C. Azelastine nasal spray for topical treatment of allergic rhinopathy. Atemw.-Lungenkrkb. Jabrgang., 19 : 1-7, 1993.
12. MCARTHUR J. G. A comparison of budesonide and beclomethasone dipropionate sprays in the treatment of seasonal allergic rhinitis. Clin. Otolaryngol., 19 : 537-542, 1994.
13. WANG D., CLEMENT P., SMITZ J., DERDE M.-P. Relevance of histamine and tryptase concentrations in nasal secretions after nasal challenge with phosphate buffered saline and allergen. Mediators of inflammation, 4 : 98-102, 1995.